In a groundbreaking pilot study, researchers have successfully utilized digital technology to reduce the time cancer patients spend on their treatment. By implementing a text-messaging system, patients undergoing immunotherapy for solid tumor cancers at Penn Medicine’s Abramson Cancer Center were able to save over an hour per visit. This innovative approach not only streamlines care but also enhances the quality of life for patients by giving them back precious time. The study, led by experts from the Perelman School of Medicine at the University of Pennsylvania, highlights the potential of technology to transform healthcare delivery.

The inspiration for this project came from observing efficient systems like TSA pre-check lines, which bypass long waits. Dr. Ronac Mamtani and Dr. Erin Bange developed a platform that allows patients to report symptoms via text messages before each immunotherapy infusion. Traditionally, patients must undergo blood tests and meet with healthcare providers in person to ensure they are fit for treatment. However, with the new system, if lab results are normal and no concerning symptoms are reported, patients can skip the in-person visit and proceed directly to their infusion. The 16-question symptom check takes less than five minutes, significantly reducing waiting times.

During the trial, 16 patients who used the fast-track option saved more than 60 minutes per visit compared to 15 patients who followed the usual in-person protocol. Importantly, the safety of the fast-track system was confirmed, with no increase in post-infusion hospital visits or negative impacts on health-related quality of life. Patients expressed enthusiasm about regaining valuable time, with some noting that even saving 45 minutes would make a significant difference in their lives.

This study marks the first time digital patient-reported outcomes have been used to streamline cancer care. While some patients and providers may prefer traditional in-person visits, the team aims to offer this as an optional tool. Focus groups with healthcare providers revealed concerns and potential barriers, prompting further refinement of the system. The ultimate goal is to conduct a pragmatic trial in a real-world setting, ensuring the tool effectively meets both patient and provider needs.

The research underscores the broader challenge of minimizing unnecessary waiting times in cancer care. By addressing this issue, the team hopes to give patients more time to focus on living, rather than simply enduring the process of receiving treatment. The success of this pilot study opens up exciting possibilities for the future of cancer care delivery.